Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 28 Myelodysplastic Syndromes 9 Advanced Solid Tumors 8 Leukemia, Myelomonocytic, Chronic 6 Myeloproliferative Disorders 5 Advanced Solid Tumor 5 Ovarian Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumour 4 Small Cell Lung Carcinoma 3 Recurrence 3 Leukemia, Monocytic, Acute 3 Triple Negative Breast Neoplasms 2 Thrombocythemia, Essential 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Neoplasm Metastasis 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Biphenotypic, Acute 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Breast Neoplasms 2

Interventions

Lidocaine 1 Injections 1 Bupivacaine 1 Botulinum Toxins, Type A 1 Bevacizumab 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma × Injections × 90 days × Clear all

NCT07624890 2026-06-03

PRP-NEUROMA

Ukrainian Society of Regional Anesthesia and Pain Therapy

Phase NA Not yet recruiting

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡